Abstract
Cannabis has been widely used for various medical purposes since before year 2000 BC. Its effects are mediated by cannabinoids and stimulation of mainly G-protein coupled cannabinoid receptors. In 1971, subjects who smoked marihuana, showed a decrease in the intraocular pressure. Later investigations additionally revealed a neuroprotective effect of both ∆-9-tetrahydrocannabinol and cannabidiol (CBD). Furthermore, CBD was found to promote neurogenesis. The aim of this review is to provide an overview of the potential use of cannabinoids in the treatment of glaucoma.
| Translated title of the contribution | Should ophtalmologists recommend medical cannabis to patients with glaucoma? |
|---|---|
| Original language | Danish |
| Article number | V11170861 |
| Journal | Ugeskrift for Laeger |
| Volume | 180 |
| Pages (from-to) | 2-4 |
| ISSN | 0041-5782 |
| Publication status | Published - 16 Jul 2018 |